Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Gain Therapeutics: Tackling Rare Diseases at the Genetic Level
Nasdaq
Related Posts
Post navigation
Previous Post
Oral therapy GT-02287 shows promise in Parkinson’s mice models
Next Post
Gain Therapeutics: Tackling Rare Diseases at the Genetic Level
Latest Articles
Clear Filters
May 9, 2024
Dr. Jonas Hannestad – CMO, Gain Therapeutics – Transforming Treatment Of Neurodegenerative Diseases
Read More
February 14, 2024
Gain Therapeutics’ supercomputer-driven therapy offers potential Parkinson’s breakthrough
Read More
February 28, 2024
Swiss biotech restores motor function in mice with Parkinson’s disease
Read More
Close